PHR vs. CNXC, CBZ, ENV, ACVA, DLO, FA, PAY, PAYO, FLYW, and GETY
Should you be buying Phreesia stock or one of its competitors? The main competitors of Phreesia include Concentrix (CNXC), CBIZ (CBZ), Envestnet (ENV), ACV Auctions (ACVA), DLocal (DLO), First Advantage (FA), Paymentus (PAY), Payoneer Global (PAYO), Flywire (FLYW), and Getty Images (GETY). These companies are all part of the "business services, not elsewhere classified" industry.
Phreesia (NYSE:PHR) and Concentrix (NASDAQ:CNXC) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their institutional ownership, earnings, risk, profitability, analyst recommendations, community ranking, valuation, dividends and media sentiment.
Phreesia received 111 more outperform votes than Concentrix when rated by MarketBeat users. Likewise, 65.64% of users gave Phreesia an outperform vote while only 48.57% of users gave Concentrix an outperform vote.
92.1% of Phreesia shares are owned by institutional investors. Comparatively, 90.3% of Concentrix shares are owned by institutional investors. 5.8% of Phreesia shares are owned by insiders. Comparatively, 3.0% of Concentrix shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
Concentrix has a net margin of 3.53% compared to Phreesia's net margin of -31.87%. Concentrix's return on equity of 17.70% beat Phreesia's return on equity.
Phreesia has a beta of 0.92, indicating that its share price is 8% less volatile than the S&P 500. Comparatively, Concentrix has a beta of 0.6, indicating that its share price is 40% less volatile than the S&P 500.
In the previous week, Phreesia had 8 more articles in the media than Concentrix. MarketBeat recorded 14 mentions for Phreesia and 6 mentions for Concentrix. Concentrix's average media sentiment score of 1.03 beat Phreesia's score of 0.12 indicating that Concentrix is being referred to more favorably in the news media.
Concentrix has higher revenue and earnings than Phreesia. Phreesia is trading at a lower price-to-earnings ratio than Concentrix, indicating that it is currently the more affordable of the two stocks.
Phreesia presently has a consensus price target of $30.92, indicating a potential upside of 58.50%. Concentrix has a consensus price target of $74.75, indicating a potential upside of 21.90%. Given Phreesia's stronger consensus rating and higher possible upside, research analysts clearly believe Phreesia is more favorable than Concentrix.
Summary
Phreesia beats Concentrix on 10 of the 18 factors compared between the two stocks.
Get Phreesia News Delivered to You Automatically
Sign up to receive the latest news and ratings for PHR and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding PHR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Phreesia Competitors List
Related Companies and Tools
